http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2013, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 May 2013 09:25:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html for the full story. http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html Tue, 21 May 2013 09:25:00 -0400 AZN NKTR http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html for the full story. http://www.streetinsider.com/Press+Releases/Results+from+Phase+III+Studies+of+Naloxegol+for+Treatment+of+Opioid-Induced+Constipation+Presented+at+Digestive+Disease+Week+2013/8357727.html Tue, 21 May 2013 09:25:00 -0400 AZN NKTR http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html Tue, 14 May 2013 10:10:00 -0400 AZN AZN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8335317.html Tue, 14 May 2013 10:10:00 -0400 AZN AZN http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Rumors/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Optimer+Pharmaceuticals+%28OPTR%29+Jumps+as+AstraZeneca+%28AZN%29%2C+Cubist+%28CBST%29+Submit+First+Round+Bids/8331970.html Mon, 13 May 2013 15:57:40 -0400 AZN CBST OPTR http://www.streetinsider.com/Press+Releases/Assessing+Your+Asthma+is+Key+to+Taking+Control/8331757.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Assessing+Your+Asthma+is+Key+to+Taking+Control/8331757.html for the full story. http://www.streetinsider.com/Press+Releases/Assessing+Your+Asthma+is+Key+to+Taking+Control/8331757.html Mon, 13 May 2013 15:00:00 -0400 AZN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html Wed, 08 May 2013 09:13:00 -0400 AZN AZN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316522.html Wed, 08 May 2013 09:13:00 -0400 AZN AZN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html Wed, 08 May 2013 09:05:00 -0400 AZN AZN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ASTRAZENECA+PLC+++++++++++For%3A+May+08/8316489.html Wed, 08 May 2013 09:05:00 -0400 AZN AZN http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html for the full story. http://www.streetinsider.com/Press+Releases/Sub-Group+Analysis+Shows+Investigational+Metreleptin+Treatment+Demonstrated+Reductions+in+HbA1c%2C+Triglycerides+and+Liver+Function+Tests+in+Pediatric+Patients+with+Lipodystrophy+During+a+12-Month+Perio/8306146.html Mon, 06 May 2013 07:00:00 -0400 A.19655944 A.31066700 A.38983148 AZN AZN BMY